Past Conferences on the State of the Science on Development and Use of New Approach Methods (NAMs) for Chemical Safety Testing
In 2019, EPA committed to developing and implementing a work plan to reduce the use of animals in chemical testing and to prioritize ongoing efforts, and to direct existing resources, toward additional activities that will demonstrate measurable impacts in the reduction of animal testing while ensuring protection of human health and the environment. To report progress on these activities, EPA hosts regular conferences to provide updates and solicit input from interested stakeholders.
Directive to Prioritize Efforts to Reduce Animal Testing
On this page:
First NAMs Conference
Location
The Conference was held on December 17, 2019 in EPA’s William Jefferson Clinton East Building at Headquarters in Washington, D.C. and made available by webinar.
Conference Agenda and Materials
Second NAMs Conference
EPA hosted the Second Conference on the State of the Science on Development and Use of New Approach Methods (NAMs) for Chemical Safety Testing virtually on October 19 & 20, 2020.
Date
The conference was held virtually October 19-20, 2020
Conference Agenda, Presentations, Recordings and Materials
2020 Agenda
Conference Summary
Recording of Day One
Recording of Day Two
Presentation |
Presenter |
Affiliation |
---|---|---|
Russell Thomas |
EPA |
|
Progress on Implementing the TSCA Alternatives Strategic Plan |
Gino Scarano |
EPA |
Andreas Bender |
Cambridge |
|
Transcriptome-Based Derivation of an In Vivo POD: Current and Future Utility |
Kamin Johnson |
Corteva |
“Fit for Purpose” for Organotypic Models in Environmental Health Protection |
Ivan Rusyn |
Texas A&M |
Retrofitting an Estrogen Receptor Transactivation Assay with Metabolic Competence |
Chad Deisenroth |
EPA |
In Vitro Disposition of Tox21 Chemicals: Initial Results and Next Steps |
David Crizer |
NTP6 |
Clemens Wittwehr |
JRC |
|
Case Study #1: Integration of NAM Data for Evaluating Potential Developmental Neurotoxicity |
Monique Perron |
EPA |
Case Study #2: Integration of NAM Data in a Next Generation Risk Assessment for Cosmetic Ingredients |
Andrew White |
Unilever |
Todd Stedeford |
EPA |